Clinical Study

Nonmotor Symptoms in Patients with PARK2 Mutations

Table 2

The findings of 123IMIBG myocardial scintigraphy in PARK2 patients.

Case12357891011121314average ± SD

Examined age655546417670636161605744
Early H/M2.271.641.911.751.522.051.751.661.231.751.622.35
Delay H/M2.141.331.671.931.342.931.651.541.151.401.602.35

H/M: the heart to mediastinum uptake ratio of 123IMIBG.